Literature DB >> 1612309

Abdominal CT following liver transplantation.

P B Shyn1, H I Goldberg.   

Abstract

Computed tomography (CT) is one of several imaging modalities employed in the evaluation of complications following orthotopic liver transplantation. Abdominal CT scans were performed in 92 (48%) of the first 190 liver transplant patients at our institution. These studies were retrospectively reviewed to determine the indications for CT in this population and to determine the incidences of the various CT findings. The major indication (70%) was detection of bile leakage, hemorrhage, or abscess. The role of CT was primarily to discover such abnormal fluid collections and guide their percutaneous drainage. This article describes a wide spectrum of common and uncommon findings following liver transplantation and illustrates their CT features.

Entities:  

Mesh:

Year:  1992        PMID: 1612309     DOI: 10.1007/bf01888556

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN: 0364-2356


  16 in total

1.  Pictorial essay. Imaging of and intervention for biliary complications after hepatic transplantation.

Authors:  J G Letourneau; D W Hunter; W D Payne; D L Day
Journal:  AJR Am J Roentgenol       Date:  1990-04       Impact factor: 3.959

2.  Periportal low-attenuation areas on CT: value as evidence of liver transplant rejection.

Authors:  S B Kaplan; J H Sumkin; W L Campbell; A B Zajko; A J Demetris
Journal:  AJR Am J Roentgenol       Date:  1989-02       Impact factor: 3.959

3.  Adrenal hemorrhage after liver transplantation.

Authors:  A D Bowen; P J Keslar; B Newman; Y Hashida
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

Review 4.  Liver transplantation (1).

Authors:  T E Starzl; A J Demetris; D Van Thiel
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

5.  The periportal collar: a CT sign of liver transplant rejection.

Authors:  R J Wechsler; S J Munoz; L Needleman; A B Kurtz; C L Miller; S L Yang; W C Maddrey; B E Jarrell
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

Review 6.  Is liver transplantation justified for the treatment of hepatic malignancies?

Authors:  K M Olthoff; J M Millis; M H Rosove; L I Goldstein; K P Ramming; R W Busuttil
Journal:  Arch Surg       Date:  1990-10

7.  Main autopsy findings in liver transplant patients.

Authors:  R S Markin; S Hollins; R P Wood; B W Shaw
Journal:  Mod Pathol       Date:  1989-07       Impact factor: 7.842

8.  Vascular complications after liver transplantation: a 5-year experience.

Authors:  P Wozney; A B Zajko; K M Bron; S Point; T E Starzl
Journal:  AJR Am J Roentgenol       Date:  1986-10       Impact factor: 3.959

9.  Posttransplantation cyclosporine-induced lymphoproliferative disorders: clinical and radiologic manifestations.

Authors:  K M Harris; M L Schwartz; B S Slasky; M Nalesnik; L Makowka
Journal:  Radiology       Date:  1987-03       Impact factor: 11.105

10.  Right adrenal gland hemorrhage as a complication of liver transplantation: CT appearance.

Authors:  N Solomon; J Sumkin
Journal:  J Comput Assist Tomogr       Date:  1988 Jan-Feb       Impact factor: 1.826

View more
  3 in total

1.  Computed tomography findings in ABO-incompatible living donor liver transplantation recipients with biliary strictures.

Authors:  Sang Hyun Choi; Kyoung Won Kim; So Yeon Kim; Jin Sil Kim; Jae Hyun Kwon; Gi-Won Song; Sung-Gyu Lee
Journal:  Eur Radiol       Date:  2018-01-02       Impact factor: 5.315

2.  The role of multislice computerized tomography angiography in assessing postoperative vascular complications in liver transplant patients

Authors:  Yaşar Türk; Artür Salmaslıoğlu; Hadi Sasani
Journal:  Turk J Med Sci       Date:  2019-08-08       Impact factor: 0.973

3.  Hypoattenuating periportal halo on CT in a patient population can occur in presence of a variety of diseases.

Authors:  Susann Dressel-Böhm; Henning Richter; Patrick R Kircher; Francesca Del Chicca
Journal:  PLoS One       Date:  2022-01-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.